Tags » Patent

A very interesting article in Huffington Post about US pressure vis-a-vis India’s patent regime

Obama Has Been Fighting Doctors Without Borders For Years

Source: Huffington Post

30 Oct 2014

WASHINGTON — It’s a little unusual to see the Obama administration singing the praises of Doctors Without Borders, the Nobel Peace Prize-winning nonprofit that is shipping doctors, drugs and supplies to West Africa to combat the Ebola outbreak. 983 more words

Access To Medicines

Cipla asks government to revoke five patents held by Novartis

Source: Economic Times

30 Oct 2014

NEW DELHI: Cipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug Onbrez and launched its generic version of indacaterol at a fifth of the price, triggering another confrontation between an Indian generic company and a foreign innovator firm. 717 more words

Access To Medicines

From think tank to trade reports – IP on the boil, again

Source: Business Line

MUMBAI, OCT. 26:  

Close to 10 years after the Indian Patents Act was amended in January 2005, discussions around intellectual property are on the boil again. 587 more words

Access To Medicines

Modi’s chief economic adviser Arvind Subramanian had opposed India on IPR till recently

Source: Times of India

NEW DELHI: The man who has been appointed the chief economic adviser to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organization. 116 more words

TRIPS

Pharma Patents in India

These points are from a talk given by Pravin Anand at fieldfisher’s Pharma Patents Seminar on 16 October 2014.

1. There is an anti-patents environment in India where patent protection is provided due to the compulsion of TRIPS rather than to advance innovation. 219 more words

Patent

Bits and Pieces: Divided Patent System, Expectation of Success, Due Diligence, Access to Medicines

Here are recent articles we wrote or found interesting, as well as blog sites you may find interesting.

1. Lemley’s continuing analysis of US litigation stats now looks at outcomes of litigation in different technology sectors. 163 more words

Patent

Ranbaxy Laboratories Ltd. v. Novartis AG & Anr.

Ranbaxy Laboratories Ltd. v. Novartis AG & Anr.

Before the High Court of Delhi at New Delhi

Date of Decision: 18.10.2014

FAO(OS) No. 447 of 2014… 290 more words

Intellectual Property Rights